Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic Bronchitis in Chronic Obstructive Pulmonary Disease. Magnifying Why Smoking Cessation Still Matters Most.

Literature DB >> 27388396

Chronic Bronchitis in Chronic Obstructive Pulmonary Disease. Magnifying Why Smoking Cessation Still Matters Most.

Sharon R Rosenberg¹, Ravi Kalhan¹.

Abstract

Entities: Disease

Mesh：

Year: 2016 PMID： 27388396 PMCID： PMC5015756 DOI： 10.1513/AnnalsATS.201605-360ED

Source DB: PubMed Journal: Ann Am Thorac Soc ISSN： 2325-6621

× No keyword cloud information.

19 in total

1. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study.

Authors: R E Kanner; J E Connett; D E Williams; A S Buist
Journal: Am J Med Date: 1999-04 Impact factor: 4.965

Review 2. An integrated approach to the medical treatment of chronic obstructive pulmonary disease.

Authors: Sharon R Rosenberg; Ravi Kalhan
Journal: Med Clin North Am Date: 2012-07 Impact factor: 5.456

3. Epidemiology Standardization Project (American Thoracic Society).

Authors: B G Ferris
Journal: Am Rev Respir Dis Date: 1978-12

4. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients.

Authors: D P Tashkin; S Rennard; J Taylor Hays; D Lawrence; J P Marton; T C Lee
Journal: Respir Med Date: 2011-05-31 Impact factor: 3.415

5. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

Authors: P D Scanlon; J E Connett; L A Waller; M D Altose; W C Bailey; A S Buist; D P Tashkin
Journal: Am J Respir Crit Care Med Date: 2000-02 Impact factor: 21.405

6. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.

Authors: Leonardo M Fabbri; Peter M A Calverley; José Luis Izquierdo-Alonso; Daniela S Bundschuh; Manja Brose; Fernando J Martinez; Klaus F Rabe
Journal: Lancet Date: 2009-08-29 Impact factor: 79.321

1. Impact of tobacco-related chronic obstructive pulmonary disease on developmental trajectories of comorbidities in the Taiwan population.

Authors: Te-Wei Ho; Yi-Ju Tsai; Chun-Ta Huang; Angela Shin-Yu Lien; Feipei Lai
Journal: Sci Rep Date: 2020-12-03 Impact factor: 4.379

1 in total

Chronic Bronchitis in Chronic Obstructive Pulmonary Disease. Magnifying Why Smoking Cessation Still Matters Most.

1. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study.

Review 2. An integrated approach to the medical treatment of chronic obstructive pulmonary disease.

3. Epidemiology Standardization Project (American Thoracic Society).

4. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients.

5. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

6. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.

7. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

8. Temporal Trends in Mortality in the United States, 1969-2013.

9. Chronic mucus hypersecretion in COPD and death from pulmonary infection.

10. COPD surveillance--United States, 1999-2011.

1. Impact of tobacco-related chronic obstructive pulmonary disease on developmental trajectories of comorbidities in the Taiwan population.